This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various drugs, especially those targeting central nervous system disorders. Its structure, featuring a benzonitrile group and a methylpiperazine moiety, makes it valuable for designing molecules with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, it is employed in medicinal chemistry for lead optimization and structure-activity relationship (SAR) studies to enhance drug efficacy and selectivity.